Reviva Pharmaceuticals Holdings, Inc. ( RVPH) - Stock Earnings
RVPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.0 million USD | — USD |
| 2025Q4 | -3.4 million USD | — USD |
| 2026Q1 | -3.2 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RVPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.3 million USD | — USD |
| 2024 | -29.9 million USD | — USD |
| 2025 | -19.9 million USD | — USD |
| 2026 Est. | — | — |
RVPH
Price: $0.72
52 week price:
Earnings Per Share: -3.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71600
Market Capitalization: 2.1 million